Wyden Announces Finance Committee Hearing on Pharmacy Benefit Managers and the Prescription Drug Supply Chain
WASHINGTON, D.C. – Senate Finance Committee Chair Ron Wyden, D-Ore., will convene a committee hearing on Thursday, March 30, 2023 titled “Pharmacy Benefit Managers and the Prescription Drug Supply Chain: Impact on Patients and Taxpayers.” The hearing will take place at 10:00 a.m. in Room 215 of the Dirksen Senate Office Building. The witnesses […]
Wyden Hearing Statement at Finance Committee Hearing on the President’s Trade Agenda
This morning the Finance Committee is joined by Ambassador Tai to discuss the trade agenda for the year ahead. The Biden administration, from the get-go, had a difficult job to do with respect to trade. The Trump administration’s chaotic approach turned some of our trade rivals into outright adversaries, and many of our friends into […]
Wyden, Bennet Introduce Bill to Increase Access to Mental and Behavioral Health Care for Kids, Seniors, and Low-Income Americans
Washington, D.C. — Today, U.S. Senators Ron Wyden, D-Ore., Chairman of the Senate Finance Committee, and Michael Bennet, D-Colo., member of the Senate Finance Committee, introduced the Better Mental Health Care for Americans Act to expand access to mental and behavioral health care for Americans on Medicare, Medicare Advantage, Medicare Part D, and Medicaid. “Mental […]
Wyden Statement on HRSA Announcement Breaking Up Monopoly Contract for Organ Procurement Oversight
Washington, D.C. — Senate Finance Committee Chair Ron Wyden, D-Ore., today issued a statement today after the Health Resources and Services Administration (HRSA) announced its intent to issue multiple contracts for the organ procurement and transplantation network (OPTN) contract, an important step towards breaking up a longstanding monopoly contract held by the United Network for […]
Wyden Hearing Statement at Finance Committee Hearing on the HHS Budget Proposal
The Finance Committee meets this morning with Secretary Becerra to discuss the year ahead for the Department of Health and Human Services. The President’s budget comes down to a simple proposition: helping working families and the middle class get ahead and reducing the deficit are not mutually exclusive. When it comes to health care, that […]
Wyden, Grassley, Cardin, Young Raise Alarm Over Dramatic Increase in Pancreata Procurement
Washington, D.C. – Senate Finance Committee Chair Ron Wyden (D-Ore.), and Senate Finance Committee members Chuck Grassley (R-Iowa), Ben Cardin (D-Md.), and Todd Young (R-Ind.), today announced a new effort raising concerns about organ procurement organizations (OPOs) exploiting a loophole to falsely inflate their performance after the number of pancreata procured doubled in 2021. “We […]
Wyden Statement on Treasury Guidance on CHIPS Act Tax Incentives
Washington, D.C. — Senate Finance Committee Chair Ron Wyden, D-Ore., today issued the following statement: “When the supply chains for semiconductors broke down early on in the pandemic, it became alarmingly clear that the U.S. needed to launch a revival of chip manufacturing here at home. That’s what I designed the tax incentives in the […]
Wyden Announces Hearing with United States Trade Representative Tai
WASHINGTON, D.C. – Senate Finance Committee Chair Ron Wyden, D-Ore., will convene a committee hearing on Thursday, March 23, 2023 on “The President’s 2023 Trade Policy Agenda.” The hearing will take place at 10:00 a.m. in Room 215 of the Dirksen Senate Office Building. The witness at Thursday’s hearing will be: The Honorable Katherine C. […]
Wyden Hearing Statement on the Treasury Budget Proposal
This morning the Finance Committee welcomes Treasury Secretary Janet Yellen for a hearing on the president’s budget proposal. Everyone here, regardless of political stripe, understands that the FDIC, the Fed and the Treasury Department are putting in long hours to contain the fallout of the recent bank closures. The process is moving forward under existing […]
Wyden Cheers Lower Drug Costs for Seniors Due to Inflation Rebate
Washington, D.C. – Senate Finance Committee Chair Ron Wyden, D-Ore., today cheered a Biden administration announcement showing that seniors will pay less for 27 drugs in Medicare Part B due to the Inflation Reduction Act’s inflation rebate policy, which penalizes drug manufactures when they increase prices faster than the rate of inflation. “Today’s news is […]